Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies.

Details

Serval ID
serval:BIB_96BE60BE6909
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies.
Journal
Mayo Clinic proceedings
Author(s)
Petrovic D., Pruijm M., Ponte B., Dhayat N.A., Ackermann D., Ehret G., Ansermot N., Vogt B., Martin P.Y., Stringhini S., Estoppey-Younès S., Thijs L., Zhang Z., Melgarejo J.D., Eap C.B., Staessen J.A., Bochud M., Guessous I.
ISSN
1942-5546 (Electronic)
ISSN-L
0025-6196
Publication state
Published
Issued date
12/2021
Peer-reviewed
Oui
Volume
96
Number
12
Pages
3071-3085
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries.
Families were randomly selected from the general population of northern Belgium (FLEMENGHO), from August 12, 1985, until November 22, 1990, and 3 Swiss cities (SKIPOGH), from November 25, 2009, through April 4, 2013. We measured plasma concentrations (FLEMENGHO, SKIPOGH) and 24-hour urinary excretions (SKIPOGH) of 4 methylxanthines-caffeine, paraxanthine, theobromine, and theophylline-using ultra-high-performance liquid chromatography-tandem mass spectrometry. We used enzymatic methods to estimate total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels and the Friedewald equation for low-density lipoprotein cholesterol levels in plasma. We applied sex-specific mixed models to investigate associations between methylxanthines and plasma lipids, adjusting for major confounders.
In both FLEMENGHO (N=1987; 1055 [53%] female participants) and SKIPOGH (N=990; 523 [53%] female participants), total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels increased across quartiles of plasma caffeine, paraxanthine, and theophylline (total cholesterol levels by caffeine quartiles in FLEMENGHO, male participants: 5.01±0.06 mmol/L, 5.05±0.06 mmol/L, 5.27±0.06 mmol/L, 5.62±0.06 mmol/L; female participants: 5.24±0.06 mmol/L, 5.15±0.05 mmol/L, 5.25±0.05 mmol/L, 5.42±0.05 mmol/L). Similar results were observed using urinary methylxanthines in SKIPOGH (total cholesterol levels by caffeine quartiles, male participants: 4.54±0.08 mmol/L, 4.94±0.08 mmol/L, 4.87±0.08 mmol/L, 5.27±0.09 mmol/L; female participants: 5.12±0.07 mmol/L, 5.21±0.07 mmol/L, 5.28±0.05 mmol/L, 5.28±0.07 mmol/L). Furthermore, urinary caffeine and theophylline were positively associated with high-density lipoprotein cholesterol in SKIPOGH male participants.
Plasma and urinary caffeine, paraxanthine, and theophylline were positively associated with plasma lipids, whereas the associations involving theobromine were less clear. We postulate that the positive association between caffeine intake and plasma lipids may be related to the sympathomimetic function of methylxanthines, mitigating the overall health-beneficial effect of caffeine intake.
Keywords
Adult, Belgium, Caffeine/adverse effects, Caffeine/blood, Caffeine/metabolism, Caffeine/urine, Cholesterol/blood, Cholesterol, HDL/blood, Chromatography, High Pressure Liquid, Female, Humans, Lipids/blood, Male, Middle Aged, Switzerland, Tandem Mass Spectrometry, Theobromine/adverse effects, Theobromine/blood, Theobromine/urine, Theophylline/adverse effects, Theophylline/blood, Theophylline/urine, Triglycerides/blood, Xanthines/adverse effects, Xanthines/blood, Xanthines/urine
Pubmed
Web of science
Create date
04/10/2021 8:55
Last modification date
22/01/2022 6:33
Usage data